UBS Raises PT on UnitedHealth Group Incorporated (UNH)  to $378, Maintains ‘Buy’ Rating

UnitedHealth Group Incorporated (NYSE:UNH) is one of the Top 15 Stocks to Buy in 11 Different Sectors for the Next 3 Months.

UBS Raises PT on UnitedHealth Group Incorporated (UNH)  to $378, Maintains ‘Buy’ Rating

On September 10, 2025, UBS raised its price target for UnitedHealth Group Incorporated (NYSE:UNH) from $330 to $378, maintaining a ‘Buy’ rating. The upgrade followed reaffirmation of 2025 guidance and confirmation of steady Stars ratings through 2027. UBS acknowledged risks from v28 Medicare Advantage changes in 2026 but cited management’s margin-strengthening efforts as supportive of continued growth.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare services worldwide through its UnitedHealthcare insurance arm and Optum’s analytics, pharmacy, and care delivery businesses. It is one of the Best Diversified Stocks.

While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about this cheapest AI stock.

READ NEXT: 11 Best Roth IRA Stocks to Invest in Now and 12 Best Uranium Stocks to Buy Right Now.

Disclosure: None.